HuGE Literature Finder
Records
1
-
30
| Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: does the primary disease site matter? Journal of hepato-biliary-pancreatic sciences 2021 Oct . Amini Neda, Andreatos Nikolaos, Margonis Georgios Antonios, Buettner Stefan, Wang Jaeyun, Galjart Boris, Wagner Doris, Sasaki Kazunari, Angelou Anastasios, Sun Jinger, Kamphues Carsten, Beer Andrea, Morioka Daisuke, Marie Løes Inger, Antoniou Efstathios, Imai Katsunori, Pikoulis Emmanouil, He Jin, Kaczirek Klaus, Poultsides George, Verhoef Cornelis, Lønning Per Eystein, Endo Itaru, Baba Hideo, Kornprat Peter, NAucejo Federico, Kreis Martin E, Wolfgang Christopher L, Weiss Matthew J, Safar Bashar, Burkhart Richard |
| Predictive factors for distant recurrence of colorectal cancer in patients after curative resection for stage I-III colorectal cancer in Australia. Langenbeck's archives of surgery 2021 Aug . Prabhakaran Swetha, Kong Joseph C, Chin Martin, Carne Peter, Farmer Chip, Skinner Stewart, Warrier Satish K, Bell Steph |
| Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival. Bioscience reports 2021 Apr . Wang Danyang, Liu Qingmin, Ren Yanjun, Zhang Yan, Wang Xin, Liu Bi |
| Concurrent Aspirin Use Is Associated with Improved Outcome in Rectal Cancer Patients Who Undergo Chemoradiation Therapy. Cancers 2021 Jan 13 (2): . Farrugia Mark K, Long Mark D, Mattson David M, Flaherty Leayn T, Dong Bowen, Cortes Gomez Eduardo, Wei Lei, Witkiewicz Agnieszka K, Yao Song, Kalinski Pawel, Singh Anurag |
| Comparable Performance of Deep Learning-Based to Manual-Based Tumor Segmentation in KRAS/NRAS/BRAF Mutation Prediction With MR-Based Radiomics in Rectal Cancer. Frontiers in oncology 2021 11 696706. Zhang Guangwen, Chen Lei, Liu Aie, Pan Xianpan, Shu Jun, Han Ye, Huan Yi, Zhang Jinso |
| Effect of Primary Tumor Location on Postmetastasectomy Survival in Patients with Colorectal Cancer Liver Metastasis. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2020 Nov . Chen Tien-Hua, Chen Wei-Shone, Jiang Jeng-Kai, Yang Shung-Haur, Wang Huann-Sheng, Chang Shih-Ching, Lan Yuan-Tzu, Lin Chun-Chi, Lin Hung-Hsin, Huang Sheng-Chieh, Cheng Hou-Hsuan, Chau Gar-Yang, Hsia Cheng-Yuan, Lei Hao-Jan, Chou Shu-Cheng, Chao Yee, Teng Hao-W |
| Germline and Somatic Pharmacogenomics to Refine Rectal Cancer Patients Selection for Neo-Adjuvant Chemoradiotherapy. Frontiers in pharmacology 2020 897. De Mattia Elena, Roncato Rossana, Palazzari Elisa, Toffoli Giuseppe, Cecchin Eri |
| Nut and peanut butter intake and the risk of colorectal cancer and its anatomical and molecular subtypes: the Netherlands Cohort Study. Carcinogenesis 2020 Jul . Nieuwenhuis Lisette, Simons Colinda C J M, Weijenberg Matty P, van den Brandt Piet |
| Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Apr . Wu Christina, Williams Terence M, Robb Ryan, Webb Amy, Wei Lai, Chen Wei, Mikhail Sameh, Ciombor Kristen K, Cardin Dana B, Timmers Cynthia, Krishna Somashekar G, Arnold Mark, Harzman Alan, Abdel-Misih Sherif, Roychowdhury Sameek, Bekaii-Saab Tanios, Wuthrick Ev |
| Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population. Disease markers 2020 2020 8459303. El Otmani Ihsane, El Agy Fatima, El Baradai Sanae, Bouguenouch Laila, Lahmidani Nada, El Abkari Mohammed, Benajah Dafr Allah, Toughrai Imane, El Bouhaddouti Hicham, Mouaqit Ouadii, Ibn Majdoub Hassani Karim, Mazaz Khalid, Benjelloun El Bachir, Ousadden Abdelmalek, El Rhazi Karima, Bouhafa Touria, Benbrahim Zineb, Ouldim Karim, Ibrahimi Sidi Adil, Ait Taleb Khalid, Chbani Lai |
| Genomic variation as a marker of response to neoadjuvant therapy in locally advanced rectal cancer. Molecular & cellular oncology 2020 7 (3): 1716618. Douglas Jason K, Callahan Rose E, Hothem Zachary A, Cousineau Craig S, Kawak Samer, Thibodeau Bryan J, Bergeron Shelli, Li Wei, Peeples Claire E, Wasvary Harry |
| Somatic mutation profiling and HER2 status in KRAS-positive Chinese colorectal cancer patients. Scientific reports 2019 Nov 9 (1): 16894. Dong Zhouhuan, Kong Linghong, Wan Zhiyi, Zhu Fengwei, Zhong Mei, Lv Yali, Zhao Po, Shi Huaiy |
| Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients. International journal of cancer 2019 Jun . Sclafani Francesco, Hulkki Wilson Sanna, Cunningham David, Gonzalez De Castro David, Kalaitzaki Eleftheria, Begum Ruwaida, Wotherspoon Andrew, Capdevila Jaume, Glimelius Bengt, Roselló Susana, Thomas Janet, Tait Daina, Brown Gina, Oates Jacqui, Chau I |
| ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy. Anticancer research 2019 Jun 39 (6): 2845-2853. Yoon Ghilsuk, Park Jee Young, Kim Hye Jin, Choi Gyu Seog, Kim Jong Gwang, Kang Byung Woog, Kang Min Kyu, Seo An |
| Association between KRAS G13D mutations and anastomotic recurrence in colorectal cancer: Two case reports. Medicine 2019 Mar 98 (12): e14781. Okada Satoshi, Hata Keisuke, Kawai Kazushige, Yamamoto Yoko, Tanaka Toshiaki, Nishikawa Takeshi, Sasaki Kazuhito, Kaneko Manabu, Emoto Shigenobu, Murono Koji, Nozawa Hiroa |
| Impact of primary colorectal Cancer location on the KRAS status and its prognostic value. BMC gastroenterology 2019 Mar 19 (1): 46. Xie Ming-Zhi, Li Ji-Lin, Cai Zheng-Min, Li Ke-Zhi, Hu Bang- |
| Analysis of KRAS, NRAS, BRAF, and PIK3CA mutations could predict metastases in colorectal cancer: A preliminary study. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2018 Aug . Wojas-Krawczyk Kamila, Kalinka-Warzocha Ewa, Reszka Katarzyna, Nico? Marcin, Szumi?o Justyna, Ma?dziuk S?awomir, Szczepaniak Katarzyna, Kupnicka Dorota, Lewandowski Remigiusz, Milanowski Janusz, Krawczyk Paw |
| HER2 status in patients with residual rectal cancer after preoperative chemoradiotherapy: the relationship with molecular results and clinicopathologic features. Virchows Archiv : an international journal of pathology 2018 Jul . Park Jun Seok, Yoon Ghilsuk, Kim Hye Jin, Park Soo Yeun, Choi Gyu Seog, Kang Min Kyu, Kim Jong Gwang, Jang Jung-Sik, Seo An |
| The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern. Acta oncologica (Stockholm, Sweden) 2018 Jul 1-7. Prasanna Thiru, Karapetis Christos S, Roder David, Tie Jeanne, Padbury Robert, Price Timothy, Wong Rachel, Shapiro Jeremy, Nott Louise, Lee Margaret, Chua Yu Jo, Craft Paul, Piantadosi Cynthia, Sorich Michael, Gibbs Peter, Yip Desmo |
| KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer. Scientific reports 2018 Jan 8 (1): 1445. Sclafani Francesco, Chau Ian, Cunningham David, Hahne Jens C, Vlachogiannis George, Eltahir Zakaria, Lampis Andrea, Braconi Chiara, Kalaitzaki Eleftheria, De Castro David Gonzalez, Wotherspoon Andrew, Capdevila Jaume, Glimelius Bengt, Tarazona Noelia, Begum Ruwaida, Lote Hazel, Hulkki Wilson Sanna, Mentrasti Giulia, Brown Gina, Tait Diana, Oates Jacqueline, Valeri Nico |
| Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer. BMC gastroenterology 2017 Nov 17 (1): 121. Kim Dalyong, Kim Sun Young, Lee Ji Sung, Hong Yong Sang, Kim Jeong Eun, Kim Kyu-Pyo, Kim Jihun, Jang Se Jin, Yoon Young-Kwang, Kim Tae W |
| MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis. Mutagenesis 2017 Oct 32 (5): 533-542. Schneiderova Michaela, Naccarati Alessio, Pardini Barbara, Rosa Fabio, Gaetano Cornelia Di, Jiraskova Katerina, Opattova Alena, Levy Miroslav, Veskrna Karel, Veskrnova Veronika, Buchler Tomas, Landi Stefano, Vodicka Pavel, Vymetalkova Veroni |
| Colorectal carcinoma with osseous metaplasia. Oncotarget 2017 Sep 8 (39): 65407-65413. Liu Xibo, Xu Jinghong, Chen Liro |
| Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer. World journal of gastroenterology 2017 Aug 23 (32): 5913-5924. Ntavatzikos Anastasios, Spathis Aris, Patapis Paul, Machairas Nikolaos, Peros George, Konstantoudakis Stefanos, Leventakou Danai, Panayiotides Ioannis G, Karakitsos Petros, Koumarianou An |
| Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Jul 39 (7): 1010428317709638. Peng Jianhong, Lin Junzhong, Qiu Miaozhen, Zhao Yujie, Deng Yuxiang, Shao Jianyong, Ding Peirong, Zhang Huizhong, Wan Desen, Lu Zhenhai, Pan Zhizho |
| Risk factors for brain metastases in patients with metastatic colorectal cancer. Acta oncologica (Stockholm, Sweden) 2017 May 56 (5): 639-645. Christensen Troels Dreier, Palshof Jesper Andreas, Larsen Finn Ole, Høgdall Estrid, Poulsen Tim Svenstrup, Pfeiffer Per, Jensen Benny Vittrup, Yilmaz Mette Karen, Christensen Ib Jarle, Nielsen Dor |
| Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer. PloS one 2017 12 (3): e0173345. Sarshekeh Amir Mehrvarz, Advani Shailesh, Overman Michael J, Manyam Ganiraju, Kee Bryan K, Fogelman David R, Dasari Arvind, Raghav Kanwal, Vilar Eduardo, Manuel Shanequa, Shureiqi Imad, Wolff Robert A, Patel Keyur P, Luthra Raja, Shaw Kenna, Eng Cathy, Maru Dipen M, Routbort Mark J, Meric-Bernstam Funda, Kopetz Sco |
| Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS- but not BRAF+ colorectal cancer. International journal of cancer 2016 Dec . Jayasekara Harindra, MacInnis Robert J, Williamson Elizabeth J, Hodge Allison M, Clendenning Mark, Rosty Christophe, Walters Rhiannon, Room Robin, Southey Melissa C, Jenkins Mark A, Milne Roger L, Hopper John L, Giles Graham G, Buchanan Daniel D, English Dallas |
| (18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status. The British journal of radiology 2016 May 20160212. Lovinfosse Pierre, Koopmansch Benjamin, Lambert Frederic, Jodogne Sébastien, Kustermans Gaelle, Hatt Mathieu, Visvikis Dimitris, Seidel Laurence, Polus Marc, Albert Adelin, Delvenne Philippe, Hustinx Rola |
| Locally advanced rectal cancers with simultaneous occurrence of KRAS mutation and high VEGF expression show invasive characteristics. Pathology, research and practice 2016 Feb . Krajnovi? Milena, Markovi? Bojana, Kneževi?-Ušaj Slavica, Nikoli? Ivan, Stanojevi? Maja, Nikoli? Valentina, Šilji? Marina, Jovanovi? ?upi? Snežana, Dimitrijevi? Bogom |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 20, 2022
- Content source: